flucytosine and ketoconazole

flucytosine has been researched along with ketoconazole in 209 studies

Research

Studies (209)

TimeframeStudies, this research(%)All Research%
pre-199093 (44.50)18.7374
1990's73 (34.93)18.2507
2000's30 (14.35)29.6817
2010's13 (6.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gunawardana, GP; Kelly-Borges, M; McCarthy, PJ; Pitts, TP; Pomponi, SA1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA1
Alvarado-Ramírez, E; Torres-Rodríguez, JM1
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA1
Khan, NA; Matin, A; Siddiqui, R; Stins, M; Warhurst, D1
Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA1
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL1
Jin, LJ; Samaranayake, LP; Samaranayake, YH; Seneviratne, CJ1
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD1
Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M1
Ekins, S; Williams, AJ; Xu, JJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Denning, DW; Hanson, LH; Perlman, AM; Stevens, DA1
de Gans, J; Eeftinck Schattenkerk, JK; Portegies, P; Stam, J; Tiessens, G; van Boxtel, CJ; van Ketel, RJ1
Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H1
Bayles, MA1
Van Cutsem, J1
Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P1
Bava, AJ; Negroni, R1
Büchner, T; Roos, N1
Lode, H; Schaberg, T1
al-Abedeen Jamjoom, Z; al-Hedaithy, S; Jamali, A; Jamjoom, A; Malabarey, T1
Lozano, MC; Martín, E; Parras, P1
Chotmongkol, V; Sookprasert, A1
Kujala, P; Ruutu, P1
Hernández Molina, JM; Llosá, J; Martinez Brocal, A; Ventosa, A1
Kurata, H; Matsuoka, H; Oh, K; Sumita, O; Takatori, K1
Lelarge, P; Mariot, J1
de Montclos, H; de Montclos, M; Flandrois, JP1
Cobbs, CG; Dismukes, WE; Lank, KM; Smith, KR1
Bolzinger, T; Pradinaud, R1
Gerarden, T; Hollis, R; Isenberg, HD; Levenson, D; Pfaller, MA; Smith, MA; Tucci, CB1
Carrasco, R; Cervelló, A; Navarro, V; Nieto, A; Roig, P; Salavert, M1
de Pauw, BE; Fibbe, WE; Novakova, I; van der Meer, JW; van't Wout, JW; Verhagen, CA1
Shindo, K1
Dettori, G; Manzara, S; Morace, G1
Barriere, SL1
Chatterjee, PK; Sharma, S; Singh, SM1
Arning, M; Scharf, RE; Schneider, W; Wolf, HH1
Andreassian, B; Bouttier, S; Branger, C; Elzaabi, M; Icard, P; Nussaume, O1
Brod, RD; Clarkson, JG; Culbertson, WW; Flynn, HW; Miller, D; Pflugfelder, SC1
Cook, RA; Galgiani, JN; McIntyre, KA1
Bartlett, MS; Body, BA; Espinel-Ingroff, A; Fromtling, RA; Galgiani, JN; Hall, GS; Hughes, CE; Odds, FC; Pfaller, MA; Rinaldi, MG1
Herrod, HG1
Burke, J; Johnson, EM; Pracharktam, R; Warnock, DW1
Dupont, B1
Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P1
Handrick, W; Hückel, D; Schönborn, C; Spencker, FB1
Herz, F; McKitrick, JC; Roth, EF1
Radentz, WH1
Dwernicka, B; Macura, AB1
Ray, TL1
Chuck, SL; Sande, MA1
Cotton, MF; Ransome, OJ1
Polak, A2
Longman, LP; Martin, MV1
Walsh, TJ1
Pizzo, A; Walsh, TJ1
Ackerbauer, H; Meingassner, JG; Mieth, H1
Abbott, AB; Cockayne, A; Hayward, J; Odds, FC1
Abruzzo, GK; Bulmer, GS; Fromtling, RA1
Borgers, M; Cauwenbergh, G; Vanden Bossche, H1
Davies, SP; Denning, DW; Murray, WK; Patou, G; Webb, WJ1
Cavanna, C; Garavelli, PL; Maccabruni, A; Michelone, G1
Gerarden, T; Pfaller, MA; Wenzel, RP; Yu, M1
Bottone, EJ; Cronin, DC; Poon, M; Wormser, GP1
Buffard, Y; Gabriel, B; Goudard, M; Regli, P1
Bodey, GP1
Davis, CP; Gudewicz, TM; Mader, JT1
Cabrita, J; Cachão, P; Rocha, MM; Rodrigo, JG1
Dorsch, R; Korting, HC1
Bacher, J; O'Leary, T; Pizzo, PA; Thaler, M1
Feld, R; Haron, E; Hasselback, R; Matlow, A; Patterson, B; Tuffnell, P1
Head, WS; O'Day, DM; Robinson, RD1
Barrie, T1
Meyer, RD1
Brenciaglia, MI; Cipriani, P; Ghezzi, MC; Mancini, C; Trancassini, M1
Beggs, WH; Gerding, DN; Hughes, CE; Peterson, LR1
Chapin, K; Doern, GV; Rinaldi, MG; Tubert, TA1
Abu Aisha, H; Chagla, AH; Laajam, M; Yaqoub, B1
Chan, FL; Huang, CY; Kwong, YL; Lam, KS; Woo, E; Yu, YL1
Brass, C; Espinel-Ingroff, A; Galgiani, JN; Gordon, MA; Kerkering, TM; Reiser, J1
Bevier, D; Panciera, DL1
Anandakrishnan, C; Attapattu, MC1
Ceuppens, AM; Heymans, C; Meunier, F; Van der Auwera, P1
Ito, A1
Radetsky, M; Roe, MH; Todd, JK; Wheeler, RC1
Atukorala, DN; Pothupitiya, GM1
Drouhet, E; Dupont, B1
Arosio, E; Dean, P; Lechi, A; Montesi, G; Pancera, P1
Freeman, JM; Head, WS; O'Day, DM; Robinson, RD; Stern, WH1
Ahmad, S; Gallagher, N; Johnson, RJ; Ramsey, PG1
Baudraz-Rosselet, F; Calandra, T; Francioli, P; Glauser, MP; Grigoriu, D; Ruffieux, C1
Bodet, CA; Drutz, DJ; Jorgensen, JH1
Tan, CB; Tjia, TL; Yeow, YK1
Ho, NK1
Katzenstein, D1
Irvine, AR; Jacobs, RA; O'Day, DM; Pons, VG; Stern, WH; Stone, RD; Tamura, E1
Barkve, H; Langberg, CW; Tjørstad, K1
Kostiala, AA; Kostiala, I1
Lefrock, JL; Smith, BR1
Case, P; Kaplan, W; Neuman, MA; Padhye, AA; Radcliffe, GN1
Anagnostopoulos, C; Lerner, SA; Resnekov, L; Samelson, LE1
Foster, CS; Giovanoni, R; Lass, JH; Moran-Wallace, K1
Arai, T1
Högl, F; Raab, W1
Beggs, WH; Sarosi, GA1
Roberts, DT1
Jones, HE1
Durack, DT; Perfect, JR1
Corrado, ML; Cummings, M; Eng, RH; Kramer, M1
Höffken, G; Lode, H1
Hironaga, M; Mochizuki, T; Watanabe, S1
Odds, FC1
Polak, A; Scholer, HJ; Wall, M1
Craven, PC; Graybill, JR2
Brabender, W; Hodges, GR1
Dismukes, WE; Stamm, AM1
Scholer, HJ1
Bolard, J; Brajtburg, J; Kobayashi, GS; Medoff, G1
Roselle, GA; Warth, P1
Pohjola-Sintonen, S; Ruutu, P; Tallroth, K1
Head, WS; O'Day, DM; Ray, WA; Robinson, R1
Plempel, M2
Ahearn, DG; McGlohn, MS1
Okafor, JI; TeStrake, D; Yangco, BG1
Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR1
Head, WS; O'Day, DM; Ray, WA; Robinson, RD1
Feld, R; Rusthoven, JJ; Tuffnell, PG1
Martinez-Suárez, JV; Rodriguez-Tudela, JL1
Hoeprich, PD1
Belcher, KE; Law, EJ; Spencer, SA; Still, JM1
Craig, WA; Gudmundsson, S; Turnidge, JD; Vogelman, B1
Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G1
Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B1
Bickers, DR1
al Khayat, R; Courdavault, L; Michel, C; Mignon, F; Roux, P; Viron, B1
Chotmongkol, V; Jitpimolmard, S1
Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV1
Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E1
Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH1
Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU1
Finielz, P; Guiserix, J; Michault, A; Rajaonarivelo, P; Ramdane, M1
Chiu, ML; Garcia, MT; Lima, JF; Minguez, F; Prieto, J; Salazar, EF1
Chiu, ML; Garcia, MT; Guardiola, L; Lima, JE; Minguez, F; Prieto, J1
Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J1
Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK1
Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U1
Berenguer Berenguer, J1
Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H1
Ellepola, AN; Samaranayake, LP5
Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A1
Daza, RM; Martín, JE; Martín, P; Martínez, MM; Mendaza, P; Portero, F; Sánchez, G1
Araj, GF; Daher, NK; Tabbarah, ZA1
Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M1
Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K1
Chang, HC; Chang, JJ; Chang, TC; Huang, AH1
Govender, S; Mutasa, E; Parbhoo, AH1
Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B1
Guarro, J; Llop, C; Riba, MD; Sala, J1
García, MT; Llorente, MT; Mínguez, F; Prieto, J1
Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA1
Anil, S; Ellepola, AN; Samaranayake, LP1
Torres-Rodríguez, JM; Vivas, JR1
Engelen, M; Rochette, F; Vanden Bossche, H1
del Palacio, A; Garau, M; Pereiro, M1
Fehér, J; Lengyel, G1
Bliss, JM; Gigliotti, F; Wellington, M1
Gangneux, JP; Guiguen, C; Preney, L; Théraud, M1
Al Hedaithy, SS; Fotedar, R1
Abbasoğlu, U; Cesur, S; Citak, S; Içli, F; Ozçelik, B1
Barker, KS; Homayouni, R; Lee, RE; Liu, TT; Rogers, PD; Wei, L1
Braun, JJ; de Blay, F; Pauli, G1
Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S1
Jayatilake, JA; Samaranayake, LP; Samaranayake, YH; Thein, ZM; Yau, JY; Yeung, KW1
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY1
Braga, JA; Brighenti, FL; Figueiredo, MS; Koga-Ito, CY; Pereira, DF; Salvia, AC1
Bulanda, M; Jagielski, T; Skóra, M1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1

Reviews

31 review(s) available for flucytosine and ketoconazole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
    Annales de chirurgie, 1992, Volume: 46, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Endocarditis; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recurrence; Reoperation

1992
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
    Presse medicale (Paris, France : 1983), 1992, May-30, Volume: 21, Issue:20

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections

1992
Antifungal treatment strategy in leukemia patients.
    Annals of hematology, 1992, Volume: 65, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed

1992
[Therapy of pulmonary mycoses].
    Deutsche medizinische Wochenschrift (1946), 1992, Nov-06, Volume: 117, Issue:45

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal

1992
[Systemic antifungal drugs].
    Duodecim; laaketieteellinen aikakauskirja, 1991, Volume: 107, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Mycoses; Rabbits

1991
[Systemic candidiasis].
    Annales francaises d'anesthesie et de reanimation, 1992, Volume: 11, Issue:5

    Topics: Amphotericin B; Candida; Candidiasis; Decontamination; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole

1992
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
    Lancet (London, England), 1991, Jun-29, Volume: 337, Issue:8757

    Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses

1991
Pharmacology and pharmacokinetics of traditional systemic antifungal agents.
    Pharmacotherapy, 1990, Volume: 10, Issue:6 ( Pt 3)

    Topics: Amphotericin B; Flucytosine; Humans; Ketoconazole; Miconazole

1990
Opportunistic fungal infections in immunocompromised hosts.
    Journal of the American Academy of Dermatology, 1989, Volume: 20, Issue:6

    Topics: Amphotericin B; Dermatomycoses; Flucytosine; Humans; Immunosuppression Therapy; Ketoconazole; Opportunistic Infections

1989
Systemic candidiasis.
    Dermatologic clinics, 1989, Volume: 7, Issue:2

    Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportunistic Infections; Risk Factors

1989
Recent advances in the treatment of systemic fungal infections.
    Methods and findings in experimental and clinical pharmacology, 1987, Volume: 9, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1987
Treatment of systemic fungal infections: recent progress and current problems.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1988, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles

1988
The pharmacology of agents used in the treatment of pulmonary mycoses.
    Clinics in chest medicine, 1986, Volume: 7, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Miconazole

1986
Topical and systemic antifungal agents.
    The Medical clinics of North America, 1988, Volume: 72, Issue:3

    Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses

1988
Cutaneous and mucosal manifestations of the deep mycotic infections.
    Acta dermato-venereologica. Supplementum, 1986, Volume: 121

    Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosis; Cryptococcosis; Dermatomycoses; Flucytosine; Histoplasmosis; Humans; Immunosuppression Therapy; Ketoconazole; Miconazole; Mouth Diseases; Mouth Mucosa; Mucormycosis; Mycoses; Paracoccidioidomycosis; Sporotrichosis; Travel

1986
[Action mechanism and resistance of drugs used in visceral mycoses].
    Nihon rinsho. Japanese journal of clinical medicine, 1980, Volume: 38, Issue:11

    Topics: Animals; Antifungal Agents; Candida albicans; Chemical Phenomena; Chemistry; Clotrimazole; Drug Resistance, Microbial; Flucytosine; Humans; Imidazoles; Ketoconazole; Mice; Mycoses; Piperazines

1980
The current status of systemic antifungal agents.
    The British journal of dermatology, 1982, Volume: 106, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines

1982
[Systemic antimycotic treatment].
    Deutsche medizinische Wochenschrift (1946), 1982, Sep-24, Volume: 107, Issue:38

    Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; Ketoconazole; Miconazole; Mycoses; Piperazines; Transfer Factor

1982
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
    Drugs, 1983, Volume: 25, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketoconazole; Kidney; Kidney Diseases; Kinetics; Miconazole; Mycoses; Piperazines

1983
Current therapy of pulmonary and disseminated fungal diseases.
    Chest, 1983, Volume: 83, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Mycoses; Nausea; Piperazines; Vomiting

1983
[Chemotherapy of aspergillus lung disease].
    Mykosen, 1983, Volume: 26, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Piperazines

1983
Antifungal agents useful in therapy of systemic fungal infections.
    Annual review of pharmacology and toxicology, 1983, Volume: 23

    Topics: Amphotericin B; Animals; Antifungal Agents; Binding, Competitive; Cholesterol; Ergosterol; Flucytosine; Fungi; Humans; Imidazoles; Ketoconazole; Membranes, Artificial; Miconazole; Mycoses; Phospholipids; Piperazines; Sterols

1983
Antifungal chemotherapy.
    Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques, 1995, Volume: 44

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine

1995
Antifungal therapy: potential interactions with other classes of drugs.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses

1994
Fungal peritonitis in patients on peritoneal dialysis.
    American journal of nephrology, 1994, Volume: 14, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Drug Administration Routes; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Kidney Failure, Chronic; Length of Stay; Male; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Risk Factors; Treatment Outcome

1994
[Commonly used antifungal agents in the treatment of systemic mycoses].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis

1995
Oral candidal infections and antimycotics.
    Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles

2000
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
    Journal of veterinary pharmacology and therapeutics, 2003, Volume: 26, Issue:1

    Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs

2003
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
    Orvosi hetilap, 2003, Aug-24, Volume: 144, Issue:34

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses

2003
Antifungal pharmacotherapy for neonatal candidiasis.
    Seminars in perinatology, 2003, Volume: 27, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003

Trials

3 trial(s) available for flucytosine and ketoconazole

ArticleYear
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
    AIDS (London, England), 1992, Volume: 6, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Prospective Studies; Survival Analysis

1992
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
    The Journal of infection, 1991, Volume: 22, Issue:1

    Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Neutropenia; Prospective Studies

1991
Collaborative investigation of variables in susceptibility testing of yeasts.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:9

    Topics: Amphotericin B; Candida; Cell Division; Culture Media; Evaluation Studies as Topic; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Microbiological Techniques; Temperature; Time Factors

1990

Other Studies

175 other study(ies) available for flucytosine and ketoconazole

ArticleYear
Antifungal activity of meridine, a natural product from the marine sponge Corticium sp.
    Journal of natural products, 1992, Volume: 55, Issue:11

    Topics: Alkaloids; Animals; Antifungal Agents; DNA, Fungal; Fungi; Microbial Sensitivity Tests; Porifera

1992
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
    Bioorganic & medicinal chemistry, 2007, Jan-01, Volume: 15, Issue:1

    Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts

2007
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole

2007
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Actins; Amebicides; Amoeba; Animals; Cell Line; Cell Survival; Cycloheximide; Cytochalasin D; Cytoskeleton; Dose-Response Relationship, Drug; Endothelial Cells; Ergosterol; Humans; Ketoconazole

2007
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
    Bioorganic & medicinal chemistry, 2008, Jan-15, Volume: 16, Issue:2

    Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States

2008
In vitro antifungal susceptibilities of five species of sporothrix.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis

2008
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts

2008
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Antifungal Agents; Biofilms; Candida albicans; Cell Adhesion; Colony Count, Microbial; Culture Media; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Polystyrenes; Time Factors

2008
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae

2009
In vitro activity of thimerosal against ocular pathogenic fungi.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal

2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:11

    Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
    Bioorganic & medicinal chemistry, 2015, Sep-01, Volume: 23, Issue:17

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans

2015
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
    Diagnostic microbiology and infectious disease, 1992, Volume: 15, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Drug Antagonism; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests

1992
Drugs for treatment of fungal infections.
    The Medical letter on drugs and therapeutics, 1992, Feb-21, Volume: 34, Issue:864

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections

1992
Tropical mycoses.
    Chemotherapy, 1992, Volume: 38 Suppl 1

    Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Female; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycetoma; Mycoses; South Africa; Sporotrichosis

1992
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Chemotherapy, 1992, Volume: 38 Suppl 1

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis

1992
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
    European journal of epidemiology, 1992, Volume: 8, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles

1992
Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting.
    British journal of neurosurgery, 1992, Volume: 6, Issue:5

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Abscess; Candidiasis; Cerebral Ventricles; Cerebrospinal Fluid; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrocephalus; Itraconazole; Ketoconazole; Ventriculoperitoneal Shunt

1992
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Chemotherapy, 1992, Volume: 38, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity

1992
Itraconazole in cryptococcal meningitis in pregnancy: a case report.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1992, Volume: 75, Issue:10

    Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious

1992
In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Mycopathologia, 1992, Volume: 118, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Econazole; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests

1992
Evaluation of antifungal activity of antimycotics by automatic analyzing system.
    Mycopathologia, 1992, Volume: 118, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Antimycin A; Aspergillus niger; Ciclopirox; Flucytosine; Fungi; Griseofulvin; Image Processing, Computer-Assisted; Ketoconazole; Nystatin; Pyridones; Sodium Chloride

1992
[Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    Pathologie-biologie, 1992, Volume: 40, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Flucytosine; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests

1992
In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Therapy, Combination; Echinocandins; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic

1991
Treatment of chromoblastomycosis.
    Journal of the American Academy of Dermatology, 1991, Volume: 25, Issue:5 Pt 1

    Topics: Antifungal Agents; Chromoblastomycosis; Drug Combinations; Flucytosine; Humans; Itraconazole; Ketoconazole

1991
Candida zeylanoides: another opportunistic yeast.
    Journal of clinical microbiology, 1991, Volume: 29, Issue:8

    Topics: Amphotericin B; Candida; Catheterization, Central Venous; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Parenteral Nutrition, Total; Polymorphism, Restriction Fragment Length

1991
[Meningitis caused by Candida albicans in a male patient infected by HIV and failure of treatment with amphotericin B].
    Neurologia (Barcelona, Spain), 1991, Volume: 6, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Ketoconazole; Male; Meningitis, Fungal

1991
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
    Drugs under experimental and clinical research, 1990, Volume: 16, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged

1990
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Chemotherapy, 1991, Volume: 37, Issue:1

    Topics: Amphotericin B; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Species Specificity; Yeasts

1991
Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
    Mycopathologia, 1990, Volume: 112, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Ulcer; Disease Models, Animal; Female; Flucytosine; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Morpholines; Rabbits

1990
Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Acute Disease; Adult; Agranulocytosis; Antifungal Agents; Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Liver Function Tests; Middle Aged; Mycoses

1990
False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft.
    Annals of vascular surgery, 1990, Volume: 4, Issue:4

    Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Aorta, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Femoral Artery; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged

1990
Endogenous Candida endophthalmitis. Management without intravenous amphotericin B.
    Ophthalmology, 1990, Volume: 97, Issue:5

    Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Prognosis; Visual Acuity; Vitrectomy; Vitreous Body

1990
Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:8

    Topics: Amphotericin B; Candida; Culture Media; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Temperature; Triazoles; Yeasts

1990
Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.
    The Journal of pediatrics, 1990, Volume: 116, Issue:3

    Topics: Adolescent; Amphotericin B; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Endocrine System Diseases; Family; Female; Flucytosine; Humans; Immunoglobulin A; Immunoglobulin G; Incidence; Infant; Infections; Ketoconazole; Lung Diseases; Male; Survival Rate

1990
Drugs for treatment of fungal infections.
    The Medical letter on drugs and therapeutics, 1990, Jun-15, Volume: 32, Issue:820

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses

1990
Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Interactions; Flucytosine; Itraconazole; Ketoconazole; Methotrexate; Microbial Sensitivity Tests; Spores, Fungal; Time Factors

1989
[Treatment of mycoses and new antifungal agents].
    La Revue du praticien, 1989, Sep-01, Volume: 39, Issue:19

    Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine

1989
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
    Annales de biologie clinique, 1989, Volume: 47, Issue:9

    Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts

1989
[Infections caused by Candida krusei in newborn infants].
    Padiatrie und Padologie, 1989, Volume: 24, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Miconazole

1989
The use of 5-fluorocytosine and ketoconazole in the culture of the erythrocytic stages of Plasmodium falciparum and some tumor cell lines.
    Experientia, 1989, May-15, Volume: 45, Issue:5

    Topics: Animals; Cell Line; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Erythrocytes; Female; Flucytosine; Humans; Ketoconazole; Melanoma; Plasmodium falciparum; Tumor Cells, Cultured; Uterine Neoplasms

1989
[Effect of synthetic antifungal drugs on the adherence of Candida albicans to the mouth mucosa epithelium in vitro].
    Medycyna doswiadczalna i mikrobiologia, 1989, Volume: 41, Issue:1

    Topics: Adhesiveness; Candida albicans; Clotrimazole; Epithelium; Female; Flucytosine; Humans; Imidazoles; In Vitro Techniques; Ketoconazole; Mouth Mucosa

1989
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
    The New England journal of medicine, 1989, Sep-21, Volume: 321, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; Humans; Hyponatremia; Ketoconazole; Male; Meningitis; Middle Aged; Pancytopenia; Prognosis; Recurrence

1989
Oral ketoconazole and flucytosine for neonatal systemic candidiasis.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1989, Apr-15, Volume: 75, Issue:8

    Topics: Administration, Oral; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Male

1989
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Chemotherapy, 1987, Volume: 33, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles

1987
A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
    The Journal of antimicrobial chemotherapy, 1987, Volume: 20, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endocarditis; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rabbits

1987
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
    Mykosen, 1985, Volume: 28, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles

1985
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Journal of general microbiology, 1985, Volume: 131, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles

1985
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
    Mycopathologia, 1986, Volume: 94, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles

1986
Renal aspergilloma--a case illustrating the problems of medical therapy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1987, Volume: 2, Issue:6

    Topics: Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Ketoconazole; Kidney Diseases; Middle Aged; Nephrectomy

1987
[Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
    Minerva medica, 1988, Volume: 79, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Clotrimazole; Drug Resistance, Microbial; Female; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Male; Miconazole; Nystatin

1988
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019.
    Diagnostic microbiology and infectious disease, 1988, Volume: 11, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Echinocandins; Flucytosine; Humans; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Temperature; Time Factors

1988
In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
    Archives of pathology & laboratory medicine, 1988, Volume: 112, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests

1988
[In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
    Pathologie-biologie, 1988, Volume: 36, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine

1988
Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Aviation, space, and environmental medicine, 1987, Volume: 58, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Hyperbaric Oxygenation; Ketoconazole; Miconazole; Nystatin; Time Factors

1987
[Chromomycosis].
    Medicina cutanea ibero-latino-americana, 1987, Volume: 15, Issue:5

    Topics: Amphotericin B; Chromoblastomycosis; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Mozambique

1987
[The correlation between biotype and antifungal sensitivity of Candida albicans].
    Mykosen, 1987, Volume: 30, Issue:11

    Topics: Candida albicans; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mucous Membrane; Skin

1987
Drugs for treatment of deep fungal infection.
    The Medical letter on drugs and therapeutics, 1988, Mar-11, Volume: 30, Issue:761

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Opportunistic Infections

1988
Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    The Journal of infectious diseases, 1988, Volume: 158, Issue:1

    Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cytarabine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Neutropenia; Rabbits; Rifampin

1988
Hepatic candidiasis: an increasing problem in immunocompromised patients.
    The American journal of medicine, 1987, Volume: 83, Issue:1

    Topics: Adult; Amphotericin B; Biopsy; Candida; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunologic Deficiency Syndromes; Ketoconazole; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver; Liver Diseases; Male

1987
An outbreak of Candida parapsilosis endophthalmitis: analysis of strains by enzyme profile and antifungal susceptibility.
    The British journal of ophthalmology, 1987, Volume: 71, Issue:2

    Topics: Amphotericin B; Candida; Candidiasis; Disease Outbreaks; Drug Contamination; Endophthalmitis; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Postoperative Complications

1987
The place of elective vitrectomy in the management of patients with Candida endophthalmitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1987, Volume: 225, Issue:2

    Topics: Amphotericin B; Candidiasis; Endophthalmitis; Female; Flucytosine; Follow-Up Studies; Humans; Ketoconazole; Male; Visual Acuity; Vitrectomy

1987
The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:3

    Topics: Adhesiveness; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cheek; Dose-Response Relationship, Drug; Epithelium; Flucytosine; Humans; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Time Factors

1986
Ketoconazole and flucytosine alone and in combination against Candida spp. in a neutropenic site in rabbits.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:1

    Topics: Animals; Candida; Candida albicans; Candidiasis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Neutropenia; Rabbits

1986
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
    Journal of clinical microbiology, 1986, Volume: 24, Issue:4

    Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Culture Media; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Yeasts

1986
Cerebral phaeohyphomycosis.
    Bulletin de la Societe de pathologie exotique et de ses filiales, 1987, Volume: 80, Issue:3

    Topics: Amphotericin B; Brain Abscess; Cladosporium; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Middle Aged; Mycoses

1987
High dose ketoconazole in the treatment of cerebral aspergilloma.
    Clinical neurology and neurosurgery, 1987, Volume: 89, Issue:3

    Topics: Adult; Amphotericin B; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Female; Flucytosine; Hong Kong; Humans; Ketoconazole; Tomography, X-Ray Computed

1987
Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:9

    Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Flucytosine; Ketoconazole; Microbial Sensitivity Tests

1987
Management of cryptococcosis and toxic epidermal necrolysis in a dog.
    Journal of the American Veterinary Medical Association, 1987, Nov-01, Volume: 191, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Stevens-Johnson Syndrome

1987
Extensive subcutaneous hyphomycosis caused by Fusarium oxysporum.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1986, Volume: 24, Issue:2

    Topics: Adolescent; Dermatomycoses; Female; Flucytosine; Fusarium; Humans; Ketoconazole

1986
In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry

1986
[Progress in chemotherapeutic agents--antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 1986, Volume: 44, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Ketoconazole; Nystatin

1986
Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
    Journal of clinical microbiology, 1986, Volume: 24, Issue:4

    Topics: Amphotericin B; Animals; Candida; Candidiasis; Culture Media; Flucytosine; Humans; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests

1986
Treatment of chromomycosis with a combination of ketoconazole and 5-fluorocytosine.
    The Ceylon medical journal, 1985, Volume: 30, Issue:4

    Topics: Adult; Aged; Chromoblastomycosis; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Male; Middle Aged

1985
[Treatment Candida albicans endophthalmitis with ketoconazole].
    Medicina clinica, 1985, May-25, Volume: 84, Issue:20

    Topics: Amphotericin B; Candidiasis; Endophthalmitis; Flucytosine; Humans; Ketoconazole

1985
Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients.
    The Journal of infectious diseases, 1985, Volume: 152, Issue:3

    Topics: Adult; Aged; Amphotericin B; Bone Diseases; Candida albicans; Candidiasis; Candidiasis, Cutaneous; Eye Diseases; Female; Flucytosine; France; Heroin Dependence; Humans; Joint Diseases; Ketoconazole; Male; Middle Aged; Osteoarthritis; Scalp; Syndrome

1985
Ketoconazole: clinical evaluation in severe fungal infections.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Mycoses

1986
Drugs for treatment of systemic fungal infections.
    The Medical letter on drugs and therapeutics, 1986, Apr-11, Volume: 28, Issue:711

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses

1986
Intraocular penetration of systemically administered antifungal agents.
    Current eye research, 1985, Volume: 4, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Contamination; Eye; Flucytosine; Humans; Ketoconazole; Orbital Diseases; Postoperative Complications; Therapeutic Irrigation

1985
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
    American journal of nephrology, 1985, Volume: 5, Issue:3

    Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Prognosis

1985
Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin.
    European journal of clinical microbiology, 1985, Volume: 4, Issue:3

    Topics: Adult; Amphotericin B; Candidiasis; Conjunctivitis; Female; Flucytosine; Folliculitis; Heroin; Humans; Iran; Ketoconazole; Male; Substance-Related Disorders

1985
Simplified bioassay method for measurement of flucytosine or ketoconazole.
    Journal of clinical microbiology, 1985, Volume: 22, Issue:2

    Topics: Amphotericin B; Biological Assay; Candida; Cytosine; Flucytosine; Humans; Ketoconazole

1985
Cryptococcal meningitis.
    Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:9

    Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Cryptococcosis; Flucytosine; Follow-Up Studies; Garlic; Humans; Ketoconazole; Meningitis; Miconazole; Middle Aged; Plant Extracts; Plants, Medicinal

1985
Systemic candidiasis in premature infants experience with drug treatment.
    Annals of the Academy of Medicine, Singapore, 1985, Volume: 14, Issue:4

    Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Miconazole

1985
Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome.
    Arthritis and rheumatism, 1985, Volume: 28, Issue:12

    Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intra-Articular; Ketoconazole; Knee Joint; Male; Middle Aged

1985
Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases.
    Ophthalmology, 1985, Volume: 92, Issue:12

    Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Eye Diseases; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Ophthalmic Solutions; Therapeutic Irrigation

1985
[Cryptococcus neoformans meningoencephalitis].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1984, May-20, Volume: 104, Issue:14

    Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Male; Meningoencephalitis; Miconazole; Prognosis

1984
Broth dilution and disc diffusion methods in the susceptibility testing of pathogenic Candida albicans against four antimycotics.
    Mycopathologia, 1984, Aug-30, Volume: 87, Issue:1-2

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chlorhexidine; Clotrimazole; Drug Resistance, Microbial; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth; Stomatitis

1984
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
    Sabouraudia, 1984, Volume: 22, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles

1984
Effective systemic antifungal agents.
    American family physician, 1984, Volume: 30, Issue:6

    Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Half-Life; Humans; Infusions, Parenteral; Ketoconazole; Miconazole; Mycoses

1984
Subcutaneous phaeohyphomycosis caused by Exophiala spinifera.
    Sabouraudia, 1984, Volume: 22, Issue:6

    Topics: Flucytosine; Humans; Ketoconazole; Middle Aged; Mitosporic Fungi; Mycoses; Skin; Species Specificity

1984
Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
    Annals of internal medicine, 1980, Volume: 93, Issue:6

    Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Imidazoles; Ketoconazole; Mitral Valve; Piperazines; Recurrence

1980
Ocular toxicity of topical antifungal agents.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1981, Volume: 99, Issue:6

    Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Cornea; Eye; Flucytosine; Imidazoles; Iritis; Ketoconazole; Miconazole; Piperazines; Rabbits

1981
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Mykosen, 1981, Volume: 24, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cytosine; Drug Interactions; Econazole; Flucytosine; Imidazoles; Ketoconazole; Nystatin; Piperazines; Saccharomyces cerevisiae

1981
Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:2

    Topics: Antifungal Agents; Candida; Cytosine; Drug Resistance; Drug Synergism; Flucytosine; Imidazoles; Ketoconazole; Piperazines; Yeasts

1982
Drugs for treatments of systemic fungal infections.
    The Medical letter on drugs and therapeutics, 1982, Apr-02, Volume: 24, Issue:606

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines

1982
Therapy of superficial fungal infection.
    The Medical clinics of North America, 1982, Volume: 66, Issue:4

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Injections, Intravenous; Ketoconazole; Miconazole; Piperazines; Tinea; Tinea Versicolor

1982
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
    The Journal of infectious diseases, 1982, Volume: 146, Issue:3

    Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Meningitis; Piperazines; Rabbits

1982
Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
    Sabouraudia, 1982, Volume: 20, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Cladosporium; Drug Synergism; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Piperazines; Rifampin

1982
Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole.
    Mycopathologia, 1982, Aug-20, Volume: 79, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Female; Flucytosine; Foot Dermatoses; Humans; Imidazoles; Ketoconazole; Middle Aged; Mitosporic Fungi; Piperazines

1982
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Piperazines

1982
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
    Chemotherapy, 1982, Volume: 28, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Mice; Piperazines

1982
Antimicrobial treatment of systemic fungal infections.
    The Journal of the Kansas Medical Society, 1983, Volume: 84, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines

1983
Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
    The Journal of antimicrobial chemotherapy, 1983, Volume: 12, Issue:2

    Topics: Candida; Cytosine; Drug Interactions; Flucytosine; Ketoconazole; Microbial Sensitivity Tests

1983
Hematogenous Candida spondylitis. A case report.
    Acta medica Scandinavica, 1984, Volume: 215, Issue:1

    Topics: Amphotericin B; Candidiasis; Clindamycin; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Lumbar Vertebrae; Middle Aged; Osteomyelitis; Spondylitis

1984
Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
    Investigative ophthalmology & visual science, 1984, Volume: 25, Issue:3

    Topics: Adrenal Cortex Hormones; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Keratitis; Ketoconazole; Miconazole; Natamycin; Rabbits

1984
Drugs for treatment of systemic fungal infections.
    The Medical letter on drugs and therapeutics, 1984, Mar-30, Volume: 26, Issue:658

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses

1984
[Correlation of in vitro and in vivo actions of azole antimycotics].
    Mykosen, 1984, Volume: 27, Issue:1

    Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles

1984
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Journal of clinical microbiology, 1984, Volume: 19, Issue:3

    Topics: Amphotericin B; Candida; Culture Media; Cytosine; Drug Synergism; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Sucrose

1984
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
    The Journal of infectious diseases, 1984, Volume: 149, Issue:4

    Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred BALB C

1984
In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Culture Media; Flucytosine; Fungi; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Potassium Iodide

1984
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles

1984
Influence of the corneal epithelium on the efficacy of topical antifungal agents.
    Investigative ophthalmology & visual science, 1984, Volume: 25, Issue:7

    Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cornea; Corneal Diseases; Econazole; Epithelium; Flucytosine; Ketoconazole; Miconazole; Natamycin; Rabbits

1984
Antimycotic activity of BAY N 7133 in animal experiments.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 13, Issue:5

    Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles

1984
Systemic infection by Rhodotorula spp. in the immunocompromised host.
    The Journal of infection, 1984, Volume: 8, Issue:3

    Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liver Abscess; Male; Mitosporic Fungi; Mycoses; Rhodotorula

1984
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Flucytosine; Glucose; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry

1995
Drugs for AIDS and associated infections.
    The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine

1995
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Burns : journal of the International Society for Burn Injuries, 1995, Volume: 21, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts

1995
The postantibiotic effect of antifungal agents against common pathogenic yeasts.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:1

    Topics: Amphotericin B; Candida; Cryptococcus neoformans; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests

1994
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
    Journal of chemotherapy (Florence, Italy), 1994, Volume: 6, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin

1994
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:1

    Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies

1994
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1994, Feb-18, Volume: 36, Issue:916

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses

1994
Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
    The Southeast Asian journal of tropical medicine and public health, 1993, Volume: 24, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged

1993
Pharmacokinetics of antifungal agents.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1993, Volume: 13 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis

1993
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
    British journal of clinical pharmacology, 1995, Volume: 40, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine

1995
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1996, Feb-02, Volume: 38, Issue:967

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses

1996
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
    Journal of clinical microbiology, 1996, Volume: 34, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results

1996
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1996, Volume: 47, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Multiple; Drug Therapy, Combination; Fluconazole; Flucytosine; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Microbial Sensitivity Tests

1996
Trichoderma harzianum peritonitis in peritoneal dialysis.
    Nephron, 1996, Volume: 74, Issue:2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Bacterial Infections; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fatal Outcome; Flucytosine; Humans; Ketoconazole; Male; Mycoses; Peritoneal Dialysis; Peritonitis; Trichoderma

1996
Susceptibility of Candida albicans pretreated with ketoconazole and 5-fluorocytosine to fungicidal activity of leukocytes and serum.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 4

    Topics: Antifungal Agents; Blood Physiological Phenomena; Candida albicans; Flucytosine; Humans; Ketoconazole; Neutrophils

1995
Influence of human serum on the postantifungal effect induced by therapeutic concentrations of ketoconazole and 5-fluorocytosine.
    Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 4

    Topics: Antifungal Agents; Blood; Candida albicans; Culture Media; Flucytosine; Humans; Ketoconazole

1995
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry

1997
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet

1996
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1997, Sep-12, Volume: 39, Issue:1009

    Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens

1997
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
    Pneumonologia i alergologia polska, 1997, Volume: 65, Issue:5-6

    Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum

1997
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
    Journal of clinical microbiology, 1998, Volume: 36, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1998
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1998, Volume: 27, Issue:5

    Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin

1998
Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1998, Volume: 27, Issue:7

    Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cheek; Epithelial Cells; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Male; Microscopy, Electron, Scanning; Mouth Mucosa; Nystatin

1998
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca

1998
[Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus; Econazole; Flucytosine; Ketoconazole; Miconazole; Nystatin; Saccharomyces cerevisiae; Yeasts

1998
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
    Archives of oral biology, 1998, Volume: 43, Issue:12

    Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors

1998
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
    International journal of antimicrobial agents, 1998, Volume: 10, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests

1998
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts

1999
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Oral diseases, 1998, Volume: 4, Issue:4

    Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin

1998
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Mycoses, 1999, Volume: 42, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic

1999
Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results

2000
Cryptococcal osteomyelitis of the spine.
    The Journal of bone and joint surgery. British volume, 1999, Volume: 81, Issue:3

    Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Bone Transplantation; Child; Combined Modality Therapy; Cryptococcosis; Decompression, Surgical; Diagnosis, Differential; Female; Flucytosine; Humans; Ketoconazole; Male; Spondylitis

1999
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests

2000
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
    Mycopathologia, 1999, Volume: 148, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Flucytosine; Fungi; Hot Temperature; Humans; Ketoconazole; Multivariate Analysis; Mycoses; Reproducibility of Results; Statistics, Nonparametric; Time Factors

1999
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Time Factors

2000
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

1999
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2001, Volume: 30, Issue:8

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence

2001
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:2

    Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi

2001
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole

2003
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
    Mycoses, 2003, Volume: 46, Issue:11-12

    Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula

2003
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
    Mycoses, 2004, Volume: 47, Issue:3-4

    Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping

2004
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
    Drug metabolism and drug interactions, 2004, Volume: 20, Issue:1-2

    Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Oropharynx

2004
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Echinocandins; Flucytosine; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genome, Fungal; Humans; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Peptides, Cyclic; Polyenes; Pyrimidines

2005
[Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity?].
    Revue des maladies respiratoires, 2005, Volume: 22, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Endoscopy; Female; Flucytosine; Follow-Up Studies; Humans; Immunoglobulin E; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Prednisolone; Respiratory Hypersensitivity; Retrospective Studies; Sinusitis; Time Factors; Treatment Outcome

2005
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Mycoses, 2006, Volume: 49, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests

2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
    The new microbiologica, 2009, Volume: 32, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole

2009
The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
    Medical mycology, 2010, Volume: 48, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida glabrata; Candidiasis; Cell Adhesion; Cell Wall; Epithelial Cells; Flucytosine; Humans; Hydrophobic and Hydrophilic Interactions; Ketoconazole; Nephelometry and Turbidimetry; Nystatin

2010
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
    Mycopathologia, 2011, Volume: 172, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole

2011
Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2013, Volume: 42, Issue:7

    Topics: Adolescent; Adult; Anemia, Sickle Cell; Antifungal Agents; Antisickling Agents; Candida; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Case-Control Studies; Colony Count, Microbial; Cross-Sectional Studies; DMF Index; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; Humans; Hydroxyurea; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Saliva; Secretory Rate; Young Adult

2013
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole

2015
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016